We are live on ! Find out more
CRVO icon

CervoMed

9 hedge funds and large institutions have $774K invested in CervoMed in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $417K → $774K (+$357K)

0% less ownership

Funds ownership: 0.08%0.08% (-0%)

18% less funds holding

Funds holding: 119 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q1 2019 in Review

9 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2019, worth a combined $774K — up 86% from $417K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CRVO and 4 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $180K. The largest seller was Anson Funds Management, exiting entirely with an estimated $66K sold.

  • 9 institutional investors held CervoMed (CRVO) as of Q1 2019, down from 11 in Q4 2018.
  • Funds reported $774K of CervoMed stock for Q1 2019, up 86% quarter-over-quarter.
  • 4 funds opened new CervoMed positions in Q1 2019 and 6 closed out, a net change of -2 holders.
  • The largest CervoMed buyer in Q1 2019 was Renaissance Technologies, an estimated $180K added.
  • The largest CervoMed seller in Q1 2019 was Anson Funds Management, an estimated $66K sold.

Based on aggregated 13F filings for Q1 2019.